Poriferous
Poriferous manufactures SU-POR porous polyethylene surgical implants for craniomaxillofacial reconstruction, including cranial, orbital, facial, and patient-specific implants. The privately held Georgia-based company sells directly to surgeons and hospitals in the US and through international distribution partners, holding FDA, CE, and ANVISA regulatory clearances.
- Company typePrivate
- Founded2012
- HeadquartersNewnan, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Poriferous does
Poriferous, LLC (operating as SU-POR) is a privately held medical device manufacturer founded in 2012 and headquartered in Newnan, Georgia. The company designs, manufactures, and distributes porous polyethylene surgical implants for craniomaxillofacial reconstruction and augmentation, organized into four product categories: cranial, orbital, facial, and patient-specific implants, with approximately 20+ sub-product SKUs addressing defects ranging from burr hole covers to full cranial domes. The core SU-POR technology is a 100% porous polyethylene material with an interconnecting, omnidirectional pore structure that promotes fibrovascular tissue integration, supports long-term implant stability, and is MR Safe, non-pyrogenic, and EO sterilized. Patient-specific implants are designed from CT scans via a digital workflow with surgeon design approval and shipped as sterile kits in as little as 8 business days. The company cites 30+ years of underlying research, 1,000+ clinical publications, and 250,000+ successful procedures with a less than 0.5% reported infection rate.
Poriferous monetizes through one-time sales of standardized catalog implants and custom patient-specific devices to surgeons and hospitals, with revenue generated via direct sales in the US and an international distribution partner network abroad. Regulatory access is a foundational asset: the company holds FDA 510(k) clearance, CE 0297 marking, MDSAP ISO 13485:2016, EN ISO 13485:2016 DAkkS, and GMP ANVISA Brazil certification, enabling commercial sales across the US, EU, Brazil, and other MDSAP-participating jurisdictions. Go-to-market combines direct enterprise field sales targeting craniomaxillofacial, plastic, and oral/maxillofacial surgeons, paired with channel partners in international markets, supported by clinical evidence libraries, surgeon testimonials, and digital product catalogs. The company operates as a founder-owned LLC (Aaron Noble, founder), with 11-50 employees and no disclosed external funding rounds, M&A activity, or public reporting.
Poriferous firmographics
Firmographics- Name
- Poriferous
- Legal name
- Poriferous, LLC
- Website
- https://poriferous.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Poriferous manufactures SU-POR porous polyethylene surgical implants for craniomaxillofacial reconstruction, including cranial, orbital, facial, and patient-specific implants. The privately held Georgia-based company sells directly to surgeons and hospitals in the US and through international distribution partners, holding FDA, CE, and ANVISA regulatory clearances.
- Ownership category
- akta.pro rank
Poriferous industry classification
Industry- Product category
- Craniomaxillofacial Surgical Implants
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts) (HLAHAEAD)
- akta.pro secondary industries
- 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG)
Keywords
Where Poriferous is headquartered
LocationHeadquarters
- HQ city
- Newnan
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Poriferous business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
Revenue model
- Standard Surgical Implants: Poriferous generates revenue through the sale of pre-manufactured porous polyethylene implants for cranial, orbital, and facial reconstruction. Products are sold to surgeons and hospitals as one-time surgical implants.
- Patient-Specific Custom Implants: Custom-designed implants based on patient CT scans, manufactured to individual anatomical specifications. Ordered through a digital workflow with design approval process and shipped as a complete sterile kit.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Poriferous product offering
Product offeringCore offering
Poriferous designs, manufactures, and sells SU-POR® porous polyethylene surgical implants for craniomaxillofacial reconstruction and augmentation. The product line includes pre-manufactured cranial, orbital, and facial implant shapes as well as custom patient-specific implants designed from individual CT scans. Implants are sold to surgeons, hospitals, and international distribution partners for use in trauma, tumor resection, congenital defect, and cosmetic reconstruction procedures.
Product overview
Poriferous is a medical device company that manufactures and sells SU-POR® porous polyethylene implants for craniomaxillofacial reconstruction and augmentation. The product portfolio consists of four main product categories: Cranial Implants (including Cranial Dome, Cranial Hemisphere, Cranial Flex Grid, Temporal Flex Grid, Flex Sheet, Osteotomy Gap Filler, Pterional Implant, Orbito-zygomatic, Posterior Fossa Plate, Occipital Implant, Retrosigmoid, Mastoid, Sellar Floor, Burr Hole Cover, and universal Sheet/Block/Membrane Sheet variants), Orbital Implants (Sphere, Cor-Tec Sphere, Quadro-Port Tunnel Orbital Sphere, Conical Orbital, Channel Sheet, Single Channel Sheet, Fan Plate, Orbital Floor Plate, Floor-Tec Composite Orbital Floor, 3D Orbital Floor, Enophthalmos Wedge, and various Rim/Alteration implants), Facial Implants (ear, nasal, malar, midface, chin, and mandible implants), and Patient-Specific Implants (custom-designed to match individual patient anatomy). All products are made from biocompatible porous polyethylene with interconnecting pore structures that promote fibrovascular tissue integration.
Differentiator
Problem solved
Functional benefit
Brands
- SU-POR: Porous polyethylene surgical implants brand for craniomaxillofacial reconstruction including cranial, orbital, facial, and patient-specific implants.
Products and services
- SU-POR® Surgical Implants (Core Product Line) Biocompatible porous polyethylene implants with interconnecting, omnidirectional pore structure that promotes fibrovascular ingrowth and tissue integration, used for craniomaxillofacial reconstruction and augmentation. Sold to surgeons and hospitals worldwide under the SU-POR brand.
- Cranial Implants Porous polyethylene cranial implants for cranioplasty and reconstruction following trauma, tumor resection, congenital defects, and revision of prior implants. Supports tissue integration, provides long-term stability, and allows surgeons to shape or customize implants based on defect requirements.
- Orbital Implants Porous polyethylene orbital implants designed to restore orbital volume, support soft tissue, and enhance structural integrity following trauma, congenital defects, or tumor removal. Includes sphere, fan plate, channel sheet, and 3D orbital floor variants.
- Facial Implants Porous polyethylene facial implants designed to provide enhanced definition, volume, and structural support for both cosmetic and reconstructive applications, including auricular reconstruction for microtia patients, nasal, malar, midface, chin, and mandible augmentation.
Quantifiable outcome
- Infection rate of less than 0.5%
- +3 more outcomes
Companies that use Poriferous
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Poriferous technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Poriferous partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
Poriferous competitors and assessment
Company assessmentBroad incumbents
- Stryker: Global diversified medical device company with a significant Craniomaxillofacial (CMF) business including cranial, facial, and orbital reconstruction implants. Directly comparable to Poriferous as a competitor in CMF porous and titanium implant categories, but operates at vastly greater scale with broader neurosurgical and orthopedic portfolios.
- Zimmer Biomet: Major orthopedic and CMF implant manufacturer offering cranial, facial, and reconstructive solutions. Overlaps with Poriferous in CMF reconstruction though it is significantly larger and more diversified across joint reconstruction and dental.
- DePuy Synthes (Johnson & Johnson): Large orthopedic and neurosurgery division of J&J with a CMF and cranial reconstruction portfolio. Comparable as a broader incumbent offering overlapping cranial and facial implant products alongside a much wider trauma and spine catalog.
- Medtronic: Global medtech incumbent with neurosurgery and cranial reconstruction product lines (e.g., TiMesh, Cranial Reconstruction). Comparable as a competing supplier in hospital CMF tenders but with vastly broader portfolio and sales footprint.
Direct peers
- Matrix Surgical USA: Specialty CMF implant manufacturer offering porous polyethylene cranial and facial implants, directly competing with Poriferous in the same product category and clinical use cases.
- Integra LifeSciences: Specialized neurosurgery and CMF implant manufacturer offering cranial reconstruction, dural repair, and tissue regeneration products. Closely comparable niche focus on cranial and neurosurgical implants, making it one of the most direct competitive analogues to Poriferous.
- KLS Martin: German-headquartered specialist in craniomaxillofacial surgery implants, distractors, and surgical instruments. Directly comparable to Poriferous with a similar CMF-focused product portfolio and global distribution model.
Emerging players
- Xenco Medical: Emerging player in 3D-printed titanium spinal and CMF implants, representing the technological shift toward patient-specific 3D-printed metallic implants that competes with porous polyethylene offerings like Poriferous.
- OsteoMed (Colson Associates): Specialty CMF and neurosurgery implant company offering cranial and small-bone reconstruction products. Comparable emerging competitor in niche CMF reconstruction with overlapping customer base among craniofacial and oculoplastic surgeons.
Others
- Bacterin International (now part of Xtant Medical): Orthobiologics and specialty implant company serving CMF and orthopedic reconstruction. Comparable as an adjacent specialty implant supplier, though it focuses more on biologics than pure porous polyethylene implants.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Poriferous social profiles
Digital presencePoriferous compliance and trust
Trust signalCompliance5 records
Poriferous financial estimates
Financial estimateRevenue estimate
Valuation estimate
Poriferous leadership team
Management profileNumber of profiles
Profiles1 record
Poriferous funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Poriferous M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Poriferous
What does Poriferous do?
Poriferous designs, manufactures, and sells SU-POR® porous polyethylene surgical implants for craniomaxillofacial reconstruction and augmentation. The product line includes pre-manufactured cranial, orbital, and facial implant shapes as well as custom patient-specific implants designed from individual CT scans. Implants are sold to surgeons, hospitals, and international distribution partners for use in trauma, tumor resection, congenital defect, and cosmetic reconstruction procedures.
Is Poriferous a public or private company?
Poriferous is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Poriferous founded?
Poriferous was founded in 2012. It employs 11 to 50 people.
Where is Poriferous based?
Poriferous is headquartered in Newnan, United States, in the North America region.
How does Poriferous make money?
Two revenue lines are on record. Standard Surgical Implants are the primary driver. The others are patient-Specific Custom Implants.
Who are Poriferous's main competitors?
Broad incumbents on record are Stryker, Zimmer Biomet, DePuy Synthes (Johnson & Johnson) and Medtronic. Direct peers are Matrix Surgical USA, Integra LifeSciences and KLS Martin. Emerging players are Xenco Medical and OsteoMed (Colson Associates). Bacterin International (now part of Xtant Medical) is listed as an others.
Does Poriferous have an API?
No public API is recorded for Poriferous.
What industry is Poriferous in?
Poriferous's product category is Craniomaxillofacial Surgical Implants. Its primary akta.pro industry code is HLAHAEAD, Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts), with a secondary code of HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial). Its NAICS code is 339113 and its SIC code is 3842.